MA
TCON

MUFG Americas’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

MUFG Americas’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-3
Closed -$6K – 1253
2015
Q4 		$6K Buy
+3
New +$6K ﹤0.01% 917

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.66B AUM 14.89% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

MUFG Americas's TCON Position: Q1 2016 in Review

MUFG Americas sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2016, closing a stake of 3 shares — an estimated $6K sold.

MUFG Americas first reported a position in TCON in Q4 2015 and held it in 1 quarter. The position peaked at $6K in Q4 2015. 22 funds tracked by Wall St. Rank hold TCON as of Q1 2016.

  • MUFG Americas reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • MUFG Americas sold 3 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2016, an estimated $6K.
  • MUFG Americas first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • MUFG Americas's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $6K in Q4 2015.
  • 22 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2016.

Based on MUFG Americas's 13F filing for Q1 2016, filed 11 May 2016.